Jun 29
LOS ANGELES (AP) - A unit of Johnson & Johnson said Monday that a federal jury has ordered Abbott Laboratories to pay $1.67 billion in a patent infringement suit over the companies' rheumatoid arthritis drugs. Abbott's best-selling drug, Humira, competes with the drug Remicade, an anti-TNF class of arthritis treatments made by J&J's Centocor. That company and New York University filed a patent infringement suit against North Chicago, Ill.-based Abbott in April 2007 in the Eastern
